The Global Toxoid Vaccine Market is expected to grow with a CAGR of 4.5% from 2024 to 2030

According to a market report by Lucintel, the future of the global toxoid vaccine market looks promising with opportunities in the hospital, specialty centre, and government organization markets. The global toxoid vaccine market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 4.5% from 2024 to 2030.

The major drivers for this market are rising prevalence of infectious diseases, augmenting demand for vaccination in developing countries, and supportive initiatives by the government to encourage immunization.

In this market, diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), and tetanus, diphtheria, and pertussis (TDaP) are the major segments of toxoid vaccine market by vaccine type.

Lucintel forecasts that DTaP is expected to witness highest growth over the forecast period due to its growing usage among children to protect against the dangerous illnesses diphtheria, tetanus, and pertussis.

Within this market, hospital is expected to witness highest growth over the forecast period due to the growing number of toxoid vaccinations is given out in hospitals, particularly to infants and pregnant women.

APAC is expected to witness highest growth over the forecast period due to the rapid population growth and the rising cases of infectious illnesses among people of the region.

Bharat Biotech, Ceva, Glaxosmithkline, Grifols, Zoetis, Sanofi, Merck & Co, Emergent Biosolutions, Integrated Biotherapeutics, and Abbott are the major suppliers in the toxoid vaccine market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email roy.almaguer@lucintel.com
Tel. 972.636.5056

Related Reports

1. Pharmaceutical Contract Manufacturing Market

 

2. Medical Battery Market

 

3. Stent Market

 

4. Wheelchair Market  

5. 3D Printing Medical Device Market

6. Medical Device Market

 

7. Diagnostic Imaging Market

 

8.  Medical Lifting Sling Market

 

9.  Liquid Biopsy Market

 

10.  Stretcher Market